JP2022105649A5 - - Google Patents

Download PDF

Info

Publication number
JP2022105649A5
JP2022105649A5 JP2022084726A JP2022084726A JP2022105649A5 JP 2022105649 A5 JP2022105649 A5 JP 2022105649A5 JP 2022084726 A JP2022084726 A JP 2022084726A JP 2022084726 A JP2022084726 A JP 2022084726A JP 2022105649 A5 JP2022105649 A5 JP 2022105649A5
Authority
JP
Japan
Prior art keywords
weight
parts
tablet composition
composition according
crude drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022084726A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022105649A (ja
JP7475393B2 (ja
Filing date
Publication date
Priority claimed from JP2018104527A external-priority patent/JP7133982B2/ja
Application filed filed Critical
Publication of JP2022105649A publication Critical patent/JP2022105649A/ja
Publication of JP2022105649A5 publication Critical patent/JP2022105649A5/ja
Application granted granted Critical
Publication of JP7475393B2 publication Critical patent/JP7475393B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022084726A 2017-08-10 2022-05-24 錠剤組成物 Active JP7475393B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017156131 2017-08-10
JP2017156131 2017-08-10
JP2018104527A JP7133982B2 (ja) 2017-08-10 2018-05-31 錠剤組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2018104527A Division JP7133982B2 (ja) 2017-08-10 2018-05-31 錠剤組成物

Publications (3)

Publication Number Publication Date
JP2022105649A JP2022105649A (ja) 2022-07-14
JP2022105649A5 true JP2022105649A5 (enrdf_load_stackoverflow) 2023-04-18
JP7475393B2 JP7475393B2 (ja) 2024-04-26

Family

ID=65636911

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018104527A Active JP7133982B2 (ja) 2017-08-10 2018-05-31 錠剤組成物
JP2018104528A Active JP7602857B2 (ja) 2017-08-10 2018-05-31 加齢性肥満改善剤及び脂肪分解力改善剤
JP2022084726A Active JP7475393B2 (ja) 2017-08-10 2022-05-24 錠剤組成物
JP2022084727A Pending JP2022105650A (ja) 2017-08-10 2022-05-24 加齢性肥満改善剤及び脂肪分解力改善剤

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2018104527A Active JP7133982B2 (ja) 2017-08-10 2018-05-31 錠剤組成物
JP2018104528A Active JP7602857B2 (ja) 2017-08-10 2018-05-31 加齢性肥満改善剤及び脂肪分解力改善剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022084727A Pending JP2022105650A (ja) 2017-08-10 2022-05-24 加齢性肥満改善剤及び脂肪分解力改善剤

Country Status (1)

Country Link
JP (4) JP7133982B2 (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021161117A (ja) * 2020-03-30 2021-10-11 ロート製薬株式会社 錠剤
JP2021187801A (ja) * 2020-06-03 2021-12-13 小林製薬株式会社 脂質排泄促進剤
JP2023056439A (ja) * 2021-10-07 2023-04-19 ロート製薬株式会社 固形組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW464495B (en) * 1996-06-12 2001-11-21 Kyowa Hakko Kogyo Kk Lipid metabolic ameliorative agent
WO2008140064A1 (ja) 2007-05-07 2008-11-20 Bbk Bio Corporation 生活習慣病の予防および改善のための栄養組成物
JP4355967B2 (ja) 2008-01-25 2009-11-04 小林製薬株式会社 医薬組成物
WO2009093737A1 (ja) 2008-01-25 2009-07-30 Kobayashi Pharmaceutical Co., Ltd. 抗肥満用医薬組成物
JP2009242354A (ja) 2008-03-31 2009-10-22 Kobayashi Pharmaceut Co Ltd 医薬組成物
US20090274781A1 (en) * 2008-05-02 2009-11-05 Asgen Pharmaceutical Co., Ltd. Anti-obesity agent
JP5204587B2 (ja) * 2008-08-20 2013-06-05 株式会社タニタ 体組成予測装置および体組成判定装置
EP3459558B1 (en) 2010-06-25 2020-07-29 Aston University Glycoproteins having lipid mobilizing properties and therapeutic uses thereof
JP6086798B2 (ja) * 2013-04-25 2017-03-01 小林製薬株式会社 錠剤の製造方法
JP6407545B2 (ja) * 2014-03-28 2018-10-17 小林製薬株式会社 医薬組成物
KR101760909B1 (ko) * 2014-11-21 2017-07-24 (주)휴온스 안정성이 개선된 한방 엑기스 함유 정제 조성물 및 이의 제조방법
KR101669140B1 (ko) 2015-04-28 2016-10-26 (주)케어젠 항비만 및 항당뇨 효능을 갖는 펩타이드 및 이의 용도
CN105362766A (zh) * 2015-12-05 2016-03-02 黑龙江江恒医药科技有限公司 一种防风通圣丸及其制备方法

Similar Documents

Publication Publication Date Title
JP2022105649A5 (enrdf_load_stackoverflow)
JP6657296B2 (ja) 骨障害、軟骨障害又はその両方の管理又は改善用組成物及び方法
HRP20191094T1 (hr) Formulacije 4-amino-2-(2,6-dioksopiperidin-3-il)izoindolin-1,3-diona
JP2019510060A5 (enrdf_load_stackoverflow)
WO2013183062A3 (en) Palatable formulations of ibuprofen
JP2014532710A5 (enrdf_load_stackoverflow)
BRPI0414655B8 (pt) composição farmacêutica para o tratamento de doença vascular e cérebrovascular
HN2005000255A (es) Derivados de pirrolotriazina utiles para tratar trastornos hiper-proliferativos y enfermedades asociadas con angiogenesis
HRP20241461T1 (hr) Aprocitentan za uporabu u liječenju hipertenzije i povezanih bolesti u kombinaciji s valsartanom
HRP20220902T3 (hr) Pripravci i njihova upotreba u liječenju multiple skleroze
GT200400174A (es) Compuestos de bencimidazolona que tienen actividad agonista del receptor 5 ht4
HRP20230616T1 (hr) Disperzivni pripravci
CO2018005842A2 (es) Composición farmacéutica que comprende un potente inhibidor de urat 1
JP2009537554A5 (enrdf_load_stackoverflow)
BR112016026667A8 (pt) comprimido oralmente desintegrante para administração de avanafil, métodos associados de fabricação e uso de um inibidor de pde v
NO20082047L (no) Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme
JP2016501862A5 (enrdf_load_stackoverflow)
HK1214519A1 (zh) 雙用途硫酸鹽口服藥物組合物片劑及其使用方法
CN102885752A (zh) 中草药牙膏配方
Zihad et al. Assessment of the laxative activity of an ethanolic extract of Bambusa arundinacea (Retz.) Willd. shoot
DK2155674T3 (da) Aminoalkoxy-aryl-sulfonamidforbindelser og anvendelse heraf som 5-HT6-ligander
HRP20100208T8 (hr) Postupak liječenja akutnog rinosinusitisa
CO2020005939A2 (es) Composiciones acuosas que comprenden bilastina y mometasona
JP2018529763A5 (enrdf_load_stackoverflow)
JP2011527984A5 (enrdf_load_stackoverflow)